No Data
No Data
Express News | Sunshine Biopharma Announces Development Of An Orally Active Protease Inhibitor With Dose-Dependent Antiviral Activity In Mice With SARS-CoV-2)
Express News | Aegis Capital Reiterates Buy on Sunshine Biopharma, Maintains $15 Price Target
Sunshine Biopharma Analyst Ratings
Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 MRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma
Sunshine Biopharma Launches a New Generic Prescription Drug
US Manufacturing Index Rises To 43, Highest Since 2020
Rhiox : I'm giving her all she's got captain!
DDDDDDDDDDD OP Rhiox : me 3